X4 Pharmaceuticals, Inc.

NASDAQ:XFOR

Biotechnology

Healthcare
$2.96 +1.49%

+$0.06 today

Market cap
$302.26M
Beta
0.37
P/E (TTM)
-5.2
EPS (TTM)
-$0.79
52W Low $1.35High $4.83

Volume 1.12M

Average 0.40M

Balance Sheet

Inspect the capital base behind the business.

Assets

$290.46M

FY 2025 · Annual

+98.3% YoY

Liabilities

$104.17M

FY 2025 · Annual

-16.2% YoY

Equity

$186.29M

FY 2025 · Annual

+741.1% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents81.79M121.72M99.22M55.7M217.05M
Short-term Investments0015M46.36M35.95M
Net Receivables747K1.15M562K1.71M573K
Inventory0002.82M4.48M
Other Current Assets5.34M5.81M7.3M5.59M3.53M
Total Current Assets87.88M128.68M122.08M112.18M261.58M
Property, Plant & Equipment (Net)10.22M8.33M6.4M4.84M1.59M
Goodwill17.35M17.35M17.35M17.35M17.35M
Intangible Assets00010M9.25M
Long-term Investments1.32M0000
Tax Assets00000
Other Non-current Assets402K1.23M1.44M2.08M692K
Total Non-current Assets29.3M26.91M25.18M34.27M28.88M
Total Assets117.18M155.59M147.26M146.45M290.46M
Account Payables4.28M7.78M8.95M8.62M5.7M
Short-term Debt1.87M1.32M000
Tax Payables00000
Deferred Revenue0000464K
Other Current Liabilities2.45M6.59M8.2M13.05M4.3M
Total Current Liabilities14.02M22.32M22.86M32.88M25.76M
Long-term Debt33.14M32.3M54.57M75.43M76.29M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)0000621K
Other Non-current Liabilities826K23.3M16.12M14.59M1.5M
Total Non-current Liabilities38.74M59.21M73.3M91.42M78.41M
Total Liabilities52.76M81.54M96.16M124.3M104.17M
Common Stock28K122K167K6K91K
Retained Earnings(282.87M)(376.74M)(477.91M)(515.36M)(594.55M)
Accumulated OCI(119K)(119K)(119K)(122K)(109K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity64.41M74.05M51.1M22.15M186.29M
Total Debt39.79M38.42M58.28M78.09M77.29M
Net Debt(42M)(83.3M)(40.94M)22.39M(139.76M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$216.9M
Short-term Investments$16.8M
Receivables$1.1M
Inventory$4.6M
Other Current$2.5M
Total Current Assets$242.0M
PP&E (Net)$1.2M
Goodwill$17.4M
Intangible Assets$9.1M
Other Non-current$704.0K
Total Non-current Assets$28.3M
Total Assets$270.3M

Analysis

Selected assets total $270.3M for Latest. The largest visible component is Cash & Equivalents at $216.9M, about 80.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportNov 4, 2026
8-KCurrent reportOct 29, 2026
4Statement of changes in beneficial ownershipOct 19, 2026
8-KCurrent reportOct 8, 2026

How much cash does XFOR have?

X4 Pharmaceuticals, Inc. (XFOR) reported $217.05M in cash and equivalents in fiscal 2025.

How much debt does XFOR carry?

X4 Pharmaceuticals, Inc. (XFOR) reported $77.28M of total debt, with net debt of -$139.76M.